Global Dextran Market Growth 2023-2029

Global Dextran Market Growth 2023-2029

Dextran is a complex branched glucan (polysaccharide made of many glucose molecules) composed of chains of varying lengths. It is used medicinally as an antithrombotic (antiplatelet), to reduce blood viscosity, and as a volume expander in hypovolaemia.
LPI (LP Information)' newest research report, the “Dextran Industry Forecast” looks at past sales and reviews total world Dextran sales in 2022, providing a comprehensive analysis by region and market sector of projected Dextran sales for 2023 through 2029. With Dextran sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dextran industry.
This Insight Report provides a comprehensive analysis of the global Dextran landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dextran portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Dextran market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dextran and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dextran.
The global Dextran market size is projected to grow from US$ 203.9 million in 2022 to US$ 284.5 million in 2029; it is expected to grow at a CAGR of 284.5 from 2023 to 2029.
Currently, there are only five major suppliers in this industry, including Pharmacosmos, pK Chemicals, Meito Sangyo, Polydex Pharm and Jinyang Biological Pharmaceutical. Pharmacosmos and pK Chemicals are two global leading suppliers with both headquarter in Denmark. Meito Sangyo is the only Japan Dextran manufacturer. Polydex Pharm produces Polydex Pharm in Canada. Jinyang Biological Pharmaceutical’s production base is in China, and it also is a China leading company.
Europe is the largest consumption place, with a consumption market share nearly 58%.
This report presents a comprehensive overview, market shares, and growth opportunities of Dextran market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Dextran 20
Dextran 40
Dextran 60
Dextran 70
Other
Segmentation by application
Solutions for Injection and Infusion
Dextran Derivative
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pharmacosmos
PK Chemicals
Meito Sangyo
Polydex Pharm
Jinyang Biological Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Dextran market?
What factors are driving Dextran market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dextran market opportunities vary by end market size?
How does Dextran break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.